Open Access

Erratum to: LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer

  • Alice Chu Jiang1,
  • Lela Buckingham2,
  • William Barbanera2,
  • Amoah Yeboah Korang1,
  • Faraz Bishehsari1, 3 and
  • Joshua Melson1, 3Email author
Clinical EpigeneticsThe official journal of the Clinical Epigenetics Society20179:76

https://doi.org/10.1186/s13148-017-0375-x

Received: 19 July 2017

Accepted: 20 July 2017

Published: 27 July 2017

The original article was published in Clinical Epigenetics 2017 9:25

Erratum

After publication of the article [1] it was brought to our attention that one of the authors had their name misspelt. The fifth author should be “Faraz Bishehsari”.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Internal Medicine, Rush University Medical Center
(2)
Department of Pathology, Rush University Medical Center
(3)
Division of Digestive Diseases, Department of Internal Medicine, Rush University Medical Center

Reference

  1. Jiang A, Buckingham L, Barbanera W, Korang A, Bishesari F, Melson J. LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer. Clinical Epigenetics. 2017;9:1. doi:https://doi.org/10.1186/s13148-017-0325-7.View ArticleGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement